We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Industry Insights

Combining Coding and Biology To Engineer Human Cells content piece image
Industry Insight

Combining Coding and Biology To Engineer Human Cells

To learn more about new technologies being developed for drug discovery and cell therapy, Technology Networks spoke to bit.bio's Dr. Farah Patell-Socha and Furqan Iqbal.

What’s Hot in Synthetic Biology Right Now? content piece image
Industry Insight

What’s Hot in Synthetic Biology Right Now?

In this opinion piece, Eric Rhodes, CEO of ERS Genomics, shares his roundup of some of the most exciting innovations in synthetic biology right now.
Using Machine Learning To Enhance Biomarkers for Cancer Immunotherapy content piece image
Industry Insight

Using Machine Learning To Enhance Biomarkers for Cancer Immunotherapy

In this interview, we spoke to Rachel Marty Pyke PhD, manager of bioinformatics science at Personalis, to find out how machine learning can be used to detect genomic instability as a biomarker for cancer immunotherapy.
Bridging the Gap Between <i>In Vitro</i> and Animal Models of Liver Disease content piece image
Industry Insight

Bridging the Gap Between In Vitro and Animal Models of Liver Disease

We spoke to Dr. Audrey Dubourg, product manager at CN Bio to find out more about how its organ-on-chip platform could bridge the gap between the current 2D models and animal models, providing human-relevant insights into diseases such as non-alcoholic steatohepatitis.
Advancing Synthetic Biology With Automation content piece image
Industry Insight

Advancing Synthetic Biology With Automation

In this piece, Adam Clore explores how smart automation can help synthetic biology companies become more resilient.

The Impact of Funding on Longevity Research content piece image
Industry Insight

The Impact of Funding on Longevity Research

To find out more about how early-stage funding could improve longevity research, we had the pleasure of speaking to Garri Zmudze, executive director of the Longevity Science Foundation.
How Automation Can Help Avoid Next Generation Sequencing Errors Amid “The Great Resignation” content piece image
Industry Insight

How Automation Can Help Avoid Next Generation Sequencing Errors Amid “The Great Resignation”

Learn how automation can help to obtain high-quality next generation sequencing research data.
Developing a Sustainable Source of Squalene content piece image
Industry Insight

Developing a Sustainable Source of Squalene

Technology Networks spoke to Jason Ornstein and Barry Holtz to learn how Synshark and Phylloceuticals are working together to address current challenges associated with squalene supply and access.

Enzymatic Approaches Promise To Bring DNA Synthesis Back to Labs content piece image
Industry Insight

Enzymatic Approaches Promise To Bring DNA Synthesis Back to Labs

In this opinion piece, Dan Gibson discusses some of the common pitfalls in the DNA synthesis field and explores how a new generation of synthesis technologies could overcome these challenges.
Developing Therapeutics for Huntington’s Disease: Challenges, Opportunities and the Future content piece image
Industry Insight

Developing Therapeutics for Huntington’s Disease: Challenges, Opportunities and the Future

Dr. Christian Landles explains why it is so challenging to develop therapeutics for rare diseases such as HD, and discusses the potential of approaches that target mutant huntingtin protein to improve treatment options for HD patients.
Advertisement